Cabot Corporation $CBT Stake Decreased by Wellington Management Group LLP

Key Points

• Wellington Management cut its Cabot stake by 32.2% in the second quarter, selling 1.15 million shares and retaining approximately 2.42 million shares worth $219.5 million, or 4.68% of the company.
• Cabot reported quarterly EPS of $1.67, slightly above estimates, while revenue rose 6.4% year over year to $982 million. The company issued fiscal 2026 EPS guidance of $6.15–$6.45.
• Analysts maintain a consensus “Hold” rating with an average price target of $89, while Cabot announced a quarterly dividend of $0.4725 per share, representing a 2.3% annualized yield.

Wellington Management Group LLP cut its holdings in shares of Cabot Corporation (NYSE:CBT - Free Report) by 32.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,416,471 shares of the specialty chemicals company's stock after selling 1,149,701 shares during the period. Wellington Management Group LLP owned approximately 4.68% of Cabot worth $219,464,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio raised its stake in Cabot by 15.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company's stock valued at $80,000 after acquiring an additional 160 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Cabot by 2.6% in the fourth quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company's stock worth $417,000 after purchasing an additional 161 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Cabot by 9.6% during the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company's stock valued at $124,000 after purchasing an additional 164 shares during the period. Parallel Advisors LLC increased its holdings in shares of Cabot by 10.5% during the first quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company's stock valued at $139,000 after purchasing an additional 175 shares during the period. Finally, Swiss Life Asset Management Ltd raised its stake in shares of Cabot by 3.6% during the second quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company's stock valued at $558,000 after purchasing an additional 212 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a report on Friday, August 7th. Truist Financial set a $100.00 price target on shares of Cabot in a research report on Wednesday, August 5th. UBS Group reduced their price target on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research note on Wednesday, August 5th. Mizuho increased their price objective on shares of Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a report on Thursday, June 25th. Finally, Wall Street Zen upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Cabot has a consensus rating of "Hold" and an average target price of $89.00.

Cabot Price Performance

NYSE:CBT opened at $83.67 on Monday. The business's 50-day moving average price is $87.62 and its 200 day moving average price is $81.24. The firm has a market cap of $4.32 billion, a P/E ratio of 23.57, a PEG ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $94.53. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts' consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. During the same period in the prior year, the company earned $1.90 EPS. Cabot's revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, sell-side analysts predict that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.3%. Cabot's dividend payout ratio is currently 53.24%.

Insiders Place Their Bets

In related news, CEO Sean D. Keohane sold 2,779 shares of the firm's stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $85.50, for a total transaction of $237,604.50. Following the completion of the sale, the chief executive officer directly owned 288,873 shares in the company, valued at approximately $24,698,641.50. This trade represents a 0.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 3.08% of the company's stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source